E-Articles
#1 in Business Subscribe Email Print

You are here: Home > Health and Fitness > Obesity > Obesity Is a Genetic Predisposition

Tags

  • would
  • status
  • medical
  • developing combination
  • developing combination
  • combination products

  • Links

  • Mortgage After Bankruptcy - Credit Tips On How To Get A Mortgage To Buy Your Dream Home
  • Georgia Home Mortgage Loans: Beware of These 3 Things
  • Some Alternative Approaches To Dealing With Psoriasis
  • E-Articles - Obesity Is a Genetic Predisposition

    Recently, a study conducted at the Boston University Medical School concl
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    uded that a very small genetic change in DNA area is the leading cause of
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    obese propensity. The incriminated gene, its name is INSIG2, plays a str
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    tegic role in fat production and makes somebody more prone to be obese by
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    simply changing its normal G-status into C-status (the DNA code is made
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    p of four letters)

    The conclusion is blaming people for their obesity is
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    a bit like blaming people for being bold or short.

    I personally think t
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    he research team finding is real, but I also see a hidden danger in this
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    pproach. The danger is to accept unconditionally the fact that despite ou
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    r effort, there is no way to control our weight . The consequence might b
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    something like "don't waist your time trying to loose your, it is geneti
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    c anyways". Accepting this irreversible role of genetic is like consideri
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    ng obesity and obesity related disease as our normal situation.

    The trut
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    is that folks do not become overweight while the amount of food calories
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    is completely used by its body when performing a physical and intellectu
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    l activity. It's also a fact some people are genetically prone to be slim
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    . Of course, for this very lucky people staying thin is much easier than
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    for people having a genetic propensity for obesity. But I know that a g
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    netic predisposition to something isn't a given that it will happen to yo
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    u in any condition, it just means you may have to work harder to avoid it


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.e-article.org.ua/article/261837/e-article-Obesity-Is-a-Genetic-Predisposition.html">Obesity Is a Genetic Predisposition</a>

    BB link (for phorums):
    [url=http://www.e-article.org.ua/article/261837/e-article-Obesity-Is-a-Genetic-Predisposition.html]Obesity Is a Genetic Predisposition[/url]

    Related Articles:

    Get More Clients: Learn How to Talk About What You Do

    UK Home Owner Loan Application Reasons

    Aromatherapy Herbs and Essential Oils

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com